Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count b

Accord Healthcare, Inc. issued a Class II recall of Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in 90-count bottles (NDC 16729-456-15) and 1000-count bottles (NDC 16729-456-17), manufactured by Intas Pharmaceuticals Limited in India. The recall notice cites the product as subpotent. No additional details on distribution scope or patient impact were provided in the source.

Most relevant for: Patients taking levothyroxine sodium tablets 175 mcg from Accord Healthcare for thyroid hormone replacement therapy

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.